Clinical Trial Update: Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole [NA]

View source ↗

Summary

A clinical trial evaluating head and neck tumor hypoxia with the PET tracer 18F-Fluoromisonidazole has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• 18F-Fluoromisonidazole (18F-fluoromisonidazole)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Squamous Cell Carcinoma, Head and Neck Neoplasms | NA | Status: WITHDRAWN